Atika Capital Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Atika Capital Management’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-14,213	Closed	-$131K	–	81
2014 Q4	$131K	Hold	14,213	–	–	0.1%	66
2014 Q3	$127K	Sell	14,213 -25,087	-64%	-$183K	0.1%	63
2014 Q2	$309K	Sell	39,300 -700	-2%	-$5.29K	0.25%	60
2014 Q1	$316K	Buy	+40,000	New	+$322K	0.27%	55

Other funds holding CORV

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Atika Capital Management's CORV Position: Q1 2015 in Review

Atika Capital Management sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q1 2015, closing a stake of 14,213 shares — an estimated $131K sold.

Atika Capital Management first reported a position in CORV in Q1 2014 and held it in 4 quarters. The position peaked at $316K in Q1 2014. 32 funds tracked by Wall St. Rank hold CORV as of Q1 2015.

Atika Capital Management reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q1 2015 after selling out during the quarter.
Atika Capital Management sold 14,213 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q1 2015, an estimated $131K.
Atika Capital Management first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q1 2014 and held it in 4 quarters.
Atika Capital Management's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $316K in Q1 2014.
32 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q1 2015.

Based on Atika Capital Management's 13F filing for Q1 2015, filed 15 May 2015.